ADCK5: A Potential Drug Target for Various Diseases (G203054)

Target Name: ADCK5

NCBI ID: G203054

ADCK5

Other Name(s): ADCK5_HUMAN | Uncharacterized aarF domain-containing protein kinase 5 | aarF domain containing kinase 5 | uncharacterized aarF domain-containing protein kinase 5 | AarF domain containing kinase 5

ADCK5: A Potential Drug Target for Various Diseases

ADCK5, also known as ADCK5_HUMAN, is a protein that is expressed in various tissues of the human body. It is a member of the ADCK gene family, which encodes a protein involved in intracellular signaling. ADCK5 is highly conserved across various species, and it has been identified as a potential drug target or biomarker for various diseases.

The ADCK5 protein is involved in the intracellular signaling pathway known as the TGF-β pathway. This pathway is a well-established signaling pathway that plays a crucial role in various cellular processes, including cell growth, differentiation, and inflammation. The TGF-β pathway is activated by various factors, including mechanical stress, growth factors, and intracellular signaling molecules.

ADCK5 is a key protein that is involved in the TGF-β pathway. It is a component of the TGF-β complex, which is responsible for regulating cell growth and differentiation. The TGF-β complex is composed of several proteins, including SMAD1, SMAD4, TGF-β1, TGF-β2, and p16. These proteins work together to regulate the activity of the TGF-β pathway by modulating the activity of various signaling molecules.

One of the key functions of ADCK5 is its role in regulating the activity of the TGF-β pathway. It is a critical component of the TGF-β complex, and it functions to regulate the activity of the TGF-β receptor. The TGF-β receptor is a transmembrane protein that is involved in the TGF-β pathway. It is expressed in various tissues of the human body, including muscle, bone, and various organs.

ADCK5 is involved in regulating the activity of the TGF-β receptor by modulating its activity. It does this by interacting with the TGF-β receptor and modulating its activity. This interaction between ADCK5 and the TGF-β receptor is critical for the regulation of cellular processes, including cell growth, differentiation, and inflammation.

ADCK5 is also involved in the regulation of the TGF-β pathway by modulating the activity of various signaling molecules. It does this by interacting with several other proteins, including SMAD1, SMAD4, and p16. These proteins work together to regulate the activity of the TGF-β pathway and to modulate the activity of various signaling molecules.

In addition to its role in the TGF-β pathway, ADCK5 is also involved in the regulation of cellular processes that are important for the development and maintenance of tissues. It is involved in the regulation of cell adhesion, migration, and the formation of tissues and organs. It is also involved in the regulation of the cytoskeleton, which is responsible for the structure and stability of cells.

ADCK5 is a potential drug target or biomarker for various diseases. Its role in the TGF-β pathway and its involvement in the regulation of cellular processes that are important for the development and maintenance of tissues make it an attractive target for researchers to investigate. There is ongoing research to understand the role of ADCK5 in various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

In conclusion, ADCK5 is a protein that is involved in the intracellular signaling pathway known as the TGF-β pathway. It is a key component of the TGF-β complex and functions to regulate the activity of the TGF-β receptor. Its role in the regulation of cellular processes that are important for the development and maintenance of tissues makes it an attractive target for researchers to investigate. Further research is needed to fully understand the role of ADCK5 in various diseases.

Protein Name: AarF Domain Containing Kinase 5

Functions: The function of this protein is not yet clear. It is not known if it has protein kinase activity and what type of substrate it would phosphorylate (Ser, Thr or Tyr)

The "ADCK5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ADCK5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets